RIKEN and Kobe Hospital recruit additional patients for clinical studies on age-related macular degeneration (AMD)

The clinical study will be led by Mr Yasuo KURIMOTO, Director of Ophtalmology at Kobe City Medical Center, and Mrs Masayo TAKAHASHI of RIKEN. In the study, a suspension of retinal pigment epithelium (RPE) cells derived from other iPS cells will be transplanted. The patients will be between 50 and 85 years old.

RIKEN CDB news release, February 8, 2017

Most popular posts:

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year.

Accept or Deny